A C-terminally elongated form of PHI from porcine intestine

Cellular and Molecular Life Sciences

Volumn 56, Issue 7-8, 1999, Pages 709-713

  Eriste, E ^a   Norberg, Å ^a   Bonetto, V ^a   Nepomuceno, D ^b   Lovenberg, T W ^b   Sillard, R ^a   Jornvall H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

cAMP production; Prohormone processing; VIP PHI precursor

Indexed keywords

CYCLIC AMP; PEPTIDE HISTIDINE ISOLEUCINE AMIDE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; INTESTINE; MASS SPECTROMETRY; NONHUMAN; PROTEIN VARIANT; SWINE;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; ENZYME ACTIVATION; HUMANS; INTESTINES; MOLECULAR SEQUENCE DATA; PEPTIDE PHI; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SWINE; TRYPSIN;

EID: 0032712123     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050464     Document Type: Article

References (22)

1. 1 Tatemoto K. and Mutt V. (1980) Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285: 417-418
2. 2 Tatemoto K. (1980) Chemical assay for natural peptides: application to the isolation of candidate hormones. In: Gastrointestinal Hormones, pp. 975-977, Glass G. B. J. (ed.), Raven, New York
3. 3 Tatemoto K. and Mutt V. (1981) Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon-secretin family. Proc. Natl. Acad. Sci. USA 78: 6603-6607
4. 4 Mutt V. (1982) Hormonal peptides common to brain and intestine. Structural aspects. In: Hormones and Cell Regulation, vol. 6, pp. 259-276, Dumont J. E., Nunez J. and Schultz G. (eds), Elsevier, Amsterdam
5. 5 Mutt V. and Said S. I. (1974) Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur. J. Biochem. 42: 581-589
6. 6 Mutt V., Jorpes J. E. and Magnusson S. (1970) Structure of porcine secretin. The amino acid sequence. Eur. J. Biochem. 15: 513-519.
7. 7 Rivier J., Spiess J., Thorner M. and Vale W. (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300: 276-278
8. 8 Jörnvall H., Carlquist M., Kwauk S., Otte S. C., McIntosh C. H. S., Brown J. C. et al. (1981) Amino acid sequence and hetrogeneity of gastric inhibitory polypeptide (GIP). FEBS Lett. 123: 205-210
9. 9 Itoh N., Obata K., Yanaihara N. and Okamoto H. (1983) Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27. Nature 304: 547-549
10. 10 Lamperti E. D., Rosen K. M. and Villa-Komaroff L. (1991) Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse. Mol. Brain Res. 9: 217-231
11. 11 McFarlin D. R., Lehn D. A., Moran S. M., MacDonald M. J. and Epstein M. L. (1995) Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP). Gene 154: 211-213
12. 12 You S., Silsby J. L., Farris J. A., Foster D. N. and El Halawani, M. E. (1995) Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion. Endocrinology 136: 2602-2610
13. 13 Yiangou Y., Di Marzo V., Spokes R. A., Panico M., Morris H. R. and Bloom S. R. (1987) Isolation, characterization, and pharmacological actions of peptide histidene valine 42, a novel prepro-vasoactive intestinal peptide-derived peptide. J. Biol. Chem. 262: 14010-14013
14. 14 Cauvin A., Vandermeers A., Vandermeers-Piret M.-C., Robberecht P. and Christophe J. (1989) Variable distribution of three molecular forms of peptide histidene isoleucinamide in rat tissues: identification of the large molecular form as peptide histidene valine-(1-42). Endocrinology 125: 2645-2655
15. 15 Mutt V. (1959) Preparation of highly purified secretin. Arkiv Kemi 15: 69-74
16. 16 Lee J.-Y., Boman A., Chuanxin S., Andersson M., Jörnvall H., Mutt V. et al. (1989) Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc. Natl. Acad. Sci. USA 86: 9159-9162
17. 17 Bonetto V., Jörnvall H., Mutt V. and Sillard R. (1995) Two alternative processing pathways for preprohormone: a bioactive form of secretin. Proc. Natl. Acad. Sci. USA 92: 11985-11989
18. 18 Spokes R. A., Yiangou Y., Chrysanthou B. J., Svensson-Bowles M. P. and Bloom S. R. (1989) Effects of preprovasoactive intestinal polypeptide-derived peptides on net fluid flux in small intestine of anesthetized rats. Gastroenterology 96: 327-330
19. 19 Yiangou Y., Serrano R., Bloom S. R., Pena J. and Festenstein H. (1990) Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune system. J. Neuroimmunol. 29: 65-72
20. 20 Yiangon Y., Christophides N. D., Blank M. A., Yanaihara N., Takemoto K., Bishop A. E., Polak J. M. and Bloom S. R. (1980) Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Gastroenterology 89: 516-524
21. 21 Yiangou Y., Requejo F., Polak J. M. and Bloom S. R. (1986) Characterization of a novel prepro VIP derived peptide. Biochem. Biophys. Res. Commun. 139: 1142-1149
22. 22 Yiangou Y., Williams S. J., Bishop A. E., Polak J. M. and Bloom S. R. (1987) Peptide histidene-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome. J. Clin. Endocrinol. Metab. 64: 131-139